Trial of Cinpanemab in Early Parkinson’s Disease,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Trial of Cinpanemab in Early Parkinson’s Disease
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-08-04 , DOI: 10.1056/nejmoa2203395
Anthony E Lang ₁ , Andrew D Siderowf ₁ , Eric A Macklin ₁ , Werner Poewe ₁ , David J Brooks ₁ , Hubert H Fernandez ₁ , Olivier Rascol ₁ , Nir Giladi ₁ , Fabrizio Stocchi ₁ , Caroline M Tanner ₁ , Ronald B Postuma ₁ , David K Simon ₁ , Eduardo Tolosa ₁ , Brit Mollenhauer ₁ , Jesse M Cedarbaum ₁ , Kyle Fraser ₁ , James Xiao ₁ , Karleyton C Evans ₁ , Danielle L Graham ₁ , Inbal Sapir ₁ , Jennifer Inra ₁ , R Matthew Hutchison ₁ , Minhua Yang ₁ , Tara Fox ₁ , Samantha Budd Haeberlein ₁ , Tien Dam ₁ ,

Affiliation

From the Edmond J. Safra Program in Parkinson's Disease, University Health Network, and the University of Toronto, Toronto (A.E.L.), and the Montreal Neurological Institute, Montreal (R.B.P.); the University of Pennsylvania, Philadelphia (A.D.S.); the Biostatistics Center, Massachusetts General Hospital (E.A.M.), Beth Israel Deaconess Medical Center (D.K.S.), and Harvard Medical School (E.A.M., D.K.S.), Boston, and Biogen, Cambridge (K.F., J.X., K.C.E., D.L.G., I.S., J.I., R.M.H., M.Y., S.B.H., T.D.) - all in Massachusetts; Medizinische Universität Innsbruck, Innsbruck, Austria (W.P.); Newcastle University, Newcastle upon Tyne (D.J.B.), and Biogen, Maidenhead (T.F.) - both in the United Kingdom; Aarhus University, Aarhus, Denmark (D.J.B.); the Center for Neurological Restoration, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine - both in Cleveland (H.H.F.); Clinical Investigation Center 1436, the Departments of Clinical Pharmacology and Neurosciences, NS-PARK-French Clinical Research Infrastructure Network, NeuroToul COEN Center, INSERM, University Hospital of Toulouse, and the University of Toulouse III - both in Toulouse, France (O.R.); Tel Aviv Sourasky Medical Center, and the Sackler School of Medicine and the Sagol School of Neuroscience, Tel Aviv University - both in Tel Aviv, Israel (N.G.); University San Raffaele and IRCCS San Raffaele - both in Rome (F.S.); the University of California, San Diego, La Jolla (C.M.T.), and the San Francisco Veterans Affairs Medical Center, San Francisco (C.M.T.); the University of Barcelona, Barcelona (E.T.); the Department of Neurology, University Medical Center Göttingen, Göttingen, and Paracelsus-Elena-Klinik, Kassel - both in Germany (B.M.); and Coeruleus Clinical Sciences, Woodbridge, CT (J.M.C.).

New England Journal of Medicine, Volume 387, Issue 5, Page 408-420, August 2022.

中文翻译：